Middle East Extracorporeal Membrane Oxygenation Machine Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Middle East ECMO market valued at $15M, driven by healthcare investments and demand for oxygenators in complex treatments.

Region:Middle East

Author(s):Geetanshi

Product Code:KRAE0596

Pages:80

Published On:December 2025

About the Report

Base Year 2024

Middle East Extracorporeal Membrane Oxygenation Machine Market Overview

  • The Middle East Extracorporeal Membrane Oxygenation Machine Market is valued at USD 15 million, based on a five-year historical analysis. This growth is primarily driven by increasing healthcare investments in advanced critical care infrastructure and rising demand for oxygenators in complex treatments, supported by expanding ICU capacity and improving hospital facilities.
  • Key players in this market include Medtronic, Getinge, LivaNova, Terumo, Nipro, and MicroPort. These companies play a significant role in driving growth and maintaining high standards in the provision of ECMO systems, particularly in Gulf Cooperation Council countries, notably Saudi Arabia and the UAE, which benefit from strong public-private partnerships that prioritize tertiary hospital modernization.
  • In 2024, the Saudi Ministry of Health announced a strategic initiative to enhance critical care access by expanding ECMO services across multiple centers. This program aims to improve survival outcomes in cardiac and respiratory emergencies, reflecting broader efforts to upgrade healthcare infrastructure in the region.
Middle East Extracorporeal Membrane Oxygenation Machine Market Size

Middle East Extracorporeal Membrane Oxygenation Machine Market Segmentation

By Type:The market is segmented into various types of ECMO systems, including Veno-venous ECMO, Veno-arterial ECMO, Arterio-venous ECMO, and others. Among these, Veno-venous ECMO is the most widely used due to its effectiveness in providing respiratory support for patients with severe lung conditions. The increasing prevalence of respiratory diseases and the need for advanced life support systems in critical care settings are driving the demand for this sub-segment.

Middle East Extracorporeal Membrane Oxygenation Machine Market segmentation by Type.

By End-User:The end-user segmentation includes Hospitals, Specialty Clinics, Research Institutions, and others. Hospitals dominate this segment due to their comprehensive critical care facilities and the increasing number of patients requiring ECMO support. The growing number of specialized cardiac and respiratory care units within hospitals is further propelling the demand for ECMO machines.

Middle East Extracorporeal Membrane Oxygenation Machine Market segmentation by End-User.

Middle East Extracorporeal Membrane Oxygenation Machine Market Competitive Landscape

The Middle East Extracorporeal Membrane Oxygenation Machine Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic, Getinge Group, LivaNova, Terumo Corporation, Abbott Laboratories, Fresenius SE & Co. KGaA, Nihon Kohden Corporation, Maquet Getinge Group, Sorin Group, XENIOS AG, ELSA Medica, A.L.S. Medical, Intersurgical, Medela AG, AtriCure, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Medtronic

1949

Dublin, Ireland

Getinge Group

1904

Göteborg, Sweden

LivaNova

2015

London, UK

Terumo Corporation

1921

Tokyo, Japan

Fresenius SE & Co. KGaA

1912

Bad Homburg, Germany

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Innovation Rate

Middle East Extracorporeal Membrane Oxygenation Machine Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Respiratory Diseases:The Middle East has witnessed a significant rise in respiratory diseases, with the World Health Organization reporting over 1.6 million cases of chronic respiratory conditions in future. This surge is attributed to factors such as air pollution and smoking. The increasing patient population necessitates advanced medical interventions, including ECMO machines, to manage severe respiratory failure effectively, thereby driving market growth.
  • Advancements in ECMO Technology:Technological innovations in ECMO devices have enhanced their efficiency and usability. For instance, the introduction of compact and user-friendly ECMO systems has improved patient outcomes. In future, the global investment in medical technology is expected to reach approximately $600 billion, with a significant portion directed towards ECMO advancements. These developments are crucial in expanding the adoption of ECMO machines in the Middle East healthcare sector.
  • Rising Healthcare Expenditure:The Middle East's healthcare expenditure is projected to reach $250 billion in future, driven by government initiatives to improve healthcare infrastructure. Countries like Saudi Arabia and the UAE are investing heavily in advanced medical technologies, including ECMO systems. This increase in funding supports the procurement of ECMO machines, facilitating better healthcare delivery and enhancing the market's growth potential.

Market Challenges

  • High Cost of ECMO Machines:The high initial cost of ECMO machines, which can range from $120,000 to $350,000, poses a significant barrier to adoption in the Middle East. Many healthcare facilities, particularly in developing regions, struggle to allocate sufficient budgets for such expensive equipment. This financial constraint limits the availability of ECMO services, hindering market growth and accessibility for patients in need.
  • Limited Availability of Trained Professionals:The effective operation of ECMO machines requires specialized training, which is currently lacking in many Middle Eastern countries. According to the International ECMO Network, there are only about 250 certified ECMO specialists in the region. This shortage of trained professionals creates operational challenges and limits the implementation of ECMO technology, impacting patient care and market expansion.

Middle East Extracorporeal Membrane Oxygenation Machine Market Future Outlook

The future of the ECMO machine market in the Middle East appears promising, driven by ongoing advancements in technology and increasing healthcare investments. As governments prioritize healthcare infrastructure, the demand for ECMO systems is expected to rise. Additionally, the integration of artificial intelligence in ECMO management will enhance operational efficiency. These trends indicate a shift towards more accessible and effective respiratory care solutions, positioning the market for significant growth in the coming years.

Market Opportunities

  • Expansion of Healthcare Infrastructure:The ongoing expansion of healthcare facilities in the Middle East presents a significant opportunity for ECMO machine adoption. With over 60 new hospitals planned in future, the demand for advanced medical technologies, including ECMO systems, is expected to increase, enhancing patient care capabilities across the region.
  • Increasing Demand for Portable ECMO Systems:The rising need for portable ECMO systems is creating new market opportunities. As healthcare providers seek to improve patient mobility and reduce hospital stays, the demand for compact ECMO devices is projected to grow. This trend aligns with the broader shift towards patient-centered care, enhancing the market's potential for innovation and expansion.

Scope of the Report

SegmentSub-Segments
By Type

Veno-venous ECMO

Veno-arterial ECMO

Arterio-venous ECMO

Others

By End-User

Hospitals

Specialty Clinics

Research Institutions

Others

By Application

Cardiac Support

Respiratory Support

Extracorporeal Carbon Dioxide Removal

Others

By Patient Type

Adult Patients

Pediatric Patients

Neonatal Patients

Others

By Region

GCC Countries

Levant Region

North Africa

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

Others

By Technology

Conventional ECMO Systems

Portable ECMO Systems

Hybrid ECMO Systems

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Saudi Food and Drug Authority)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Medical Device Importers and Exporters

Industry Associations and Societies

Financial Institutions and Banks

Players Mentioned in the Report:

Medtronic

Getinge Group

LivaNova

Terumo Corporation

Abbott Laboratories

Fresenius SE & Co. KGaA

Nihon Kohden Corporation

Maquet Getinge Group

Sorin Group

XENIOS AG

ELSA Medica

A.L.S. Medical

Intersurgical

Medela AG

AtriCure, Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Middle East Extracorporeal Membrane Oxygenation Machine Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Middle East Extracorporeal Membrane Oxygenation Machine Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Middle East Extracorporeal Membrane Oxygenation Machine Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of respiratory diseases
3.1.2 Advancements in ECMO technology
3.1.3 Rising healthcare expenditure
3.1.4 Growing awareness and training programs

3.2 Market Challenges

3.2.1 High cost of ECMO machines
3.2.2 Limited availability of trained professionals
3.2.3 Regulatory hurdles
3.2.4 Maintenance and operational complexities

3.3 Market Opportunities

3.3.1 Expansion of healthcare infrastructure
3.3.2 Increasing demand for portable ECMO systems
3.3.3 Collaborations with research institutions
3.3.4 Technological innovations in ECMO devices

3.4 Market Trends

3.4.1 Shift towards minimally invasive procedures
3.4.2 Integration of AI in ECMO management
3.4.3 Focus on patient-centered care
3.4.4 Rise in telemedicine and remote monitoring

3.5 Government Regulation

3.5.1 Stricter safety and efficacy standards
3.5.2 Incentives for healthcare technology adoption
3.5.3 Guidelines for ECMO training and certification
3.5.4 Policies promoting research and development

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Middle East Extracorporeal Membrane Oxygenation Machine Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Middle East Extracorporeal Membrane Oxygenation Machine Market Segmentation

8.1 By Type

8.1.1 Veno-venous ECMO
8.1.2 Veno-arterial ECMO
8.1.3 Arterio-venous ECMO
8.1.4 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Specialty Clinics
8.2.3 Research Institutions
8.2.4 Others

8.3 By Application

8.3.1 Cardiac Support
8.3.2 Respiratory Support
8.3.3 Extracorporeal Carbon Dioxide Removal
8.3.4 Others

8.4 By Patient Type

8.4.1 Adult Patients
8.4.2 Pediatric Patients
8.4.3 Neonatal Patients
8.4.4 Others

8.5 By Region

8.5.1 GCC Countries
8.5.2 Levant Region
8.5.3 North Africa
8.5.4 Others

8.6 By Distribution Channel

8.6.1 Direct Sales
8.6.2 Distributors
8.6.3 Online Sales
8.6.4 Others

8.7 By Technology

8.7.1 Conventional ECMO Systems
8.7.2 Portable ECMO Systems
8.7.3 Hybrid ECMO Systems
8.7.4 Others

9. Middle East Extracorporeal Membrane Oxygenation Machine Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Innovation Rate
9.2.8 Distribution Efficiency
9.2.9 Brand Recognition
9.2.10 Customer Satisfaction Score

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Medtronic
9.5.2 Getinge Group
9.5.3 LivaNova
9.5.4 Terumo Corporation
9.5.5 Abbott Laboratories
9.5.6 Fresenius SE & Co. KGaA
9.5.7 Nihon Kohden Corporation
9.5.8 Maquet Getinge Group
9.5.9 Sorin Group
9.5.10 XENIOS AG
9.5.11 ELSA Medica
9.5.12 A.L.S. Medical
9.5.13 Intersurgical
9.5.14 Medela AG
9.5.15 AtriCure, Inc.

10. Middle East Extracorporeal Membrane Oxygenation Machine Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Decision-Making Processes
10.1.3 Preferred Suppliers
10.1.4 Compliance Requirements

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends in Healthcare
10.2.2 Funding Sources
10.2.3 Infrastructure Development Plans
10.2.4 Cost Management Strategies

10.3 Pain Point Analysis by End-User Category

10.3.1 Equipment Availability
10.3.2 Training and Support Needs
10.3.3 Maintenance Challenges
10.3.4 Regulatory Compliance Issues

10.4 User Readiness for Adoption

10.4.1 Training Programs
10.4.2 Infrastructure Readiness
10.4.3 Financial Preparedness
10.4.4 Technological Adaptability

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 Case Studies
10.5.3 User Feedback
10.5.4 Future Expansion Plans

11. Middle East Extracorporeal Membrane Oxygenation Machine Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from healthcare associations and medical device regulatory bodies
  • Review of published articles in medical journals focusing on ECMO technology and its applications
  • Examination of trade publications and industry white papers on the Middle East healthcare infrastructure

Primary Research

  • Interviews with cardiologists and pulmonologists specializing in ECMO procedures
  • Surveys with hospital procurement managers regarding ECMO machine purchasing trends
  • Field interviews with biomedical engineers involved in ECMO machine maintenance and operation

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and secondary data sources
  • Triangulation of market data from healthcare expenditure reports and hospital admission statistics
  • Sanity checks through feedback from a panel of industry experts and stakeholders

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total healthcare spending in the Middle East and its allocation to critical care technologies
  • Analysis of ECMO machine adoption rates across various healthcare facilities in the region
  • Incorporation of government healthcare initiatives and funding for advanced medical technologies

Bottom-up Modeling

  • Collection of sales data from leading ECMO machine manufacturers operating in the Middle East
  • Estimation of average unit prices based on product specifications and market demand
  • Volume projections based on hospital capacity and ECMO usage rates in critical care units

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating population health trends and disease prevalence rates
  • Scenario modeling based on potential changes in healthcare policies and technological advancements
  • Baseline, optimistic, and pessimistic forecasts for ECMO market growth through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Cardiology Departments100Cardiologists, Department Heads
Pulmonary Care Units80Pulmonologists, Critical Care Nurses
Hospital Procurement Teams70Procurement Managers, Supply Chain Directors
Biomedical Engineering Departments60Biomedical Engineers, Equipment Technicians
Healthcare Policy Makers50Health Administrators, Policy Analysts

Frequently Asked Questions

What is the current value of the Middle East Extracorporeal Membrane Oxygenation Machine Market?

The Middle East Extracorporeal Membrane Oxygenation Machine Market is valued at approximately USD 15 million, reflecting a five-year historical analysis that highlights growth driven by healthcare investments and the demand for advanced critical care infrastructure.

Who are the key players in the Middle East ECMO machine market?

What factors are driving the growth of the ECMO machine market in the Middle East?

What are the main challenges facing the ECMO machine market in the Middle East?

Other Regional/Country Reports

Indonesia Extracorporeal Membrane Oxygenation Machine Market

Malaysia Extracorporeal Membrane Oxygenation Machine Market

KSA Extracorporeal Membrane Oxygenation Machine Market

APAC Extracorporeal Membrane Oxygenation Machine Market

SEA Extracorporeal Membrane Oxygenation Machine Market

Vietnam Extracorporeal Membrane Oxygenation Machine Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022